Consumer behaviour study
Your Bones, Your Everyday Choices
In a Hercules online survey of 100 calcium supplement users in four Indian cities, 57% said a doctor first suggested calcium to them. 68% would buy online and 67% at a pharmacy. Price (81%) and doctor advice (80%) were the most named purchase drivers, and 77% would try a gummy or chewable.
Explore the findingsLast took a calcium supplement in the last 3 months
Named their doctor as the first suggester
Buy, or would buy, on apps and sites such as 1mg, Healthkart, Amazon
Based on 100 completed responses. Consumer behaviour study.
What we set out to answer, and what we found
We asked calcium supplement users what starts the habit and what keeps it going
Who takes calcium, and for how long?
We asked when each person last took a calcium supplement, to size current takers (past 3 months) against lapsed takers (3 to 12 months ago).
Who suggested it first?
We asked who first suggested calcium supplements, to test whether doctor advice is the trigger that messaging should lead with.
Which formats and purchase drivers matter?
We measured awareness of six formats, and which of eight purchase drivers people name in their top two.
Where do people buy, and what puts them off?
We mapped purchase channels, interest in trying a gummy or chewable, and the barriers to taking calcium regularly.
Doctors start the habit. 57.0% say their doctor first suggested calcium, against 14.0% for family or friends and 13.0% for a pharmacist. Only 8.0% picked a supplement themselves.
Most respondents are recent takers. 59.0% last took calcium in the last 3 months and 36.0% did so 3 to 12 months ago.
Price and doctor advice are the most named drivers. 81.0% put price in their top two and 80.0% put doctor's recommendation there. Format (76.0%), consistency (75.0%) and pack size (75.0%) follow closely, so no single driver stands clear.
Online and pharmacy are level. 68.0% buy or would buy online and 67.0% at a pharmacy. 77.0% name two or more channels.
Tablets and capsules are the best-known formats. Awareness is 62.0% for tablets and 58.0% for capsules, against 35.0% for liquids.
Trial intent is high, barriers are spread. 77.0% would probably or definitely try a gummy or chewable. Side effects and forgetting to take it each put off 55.0%, and cost 54.0%.
Open to a New Form
Probably or definitely would try a gummy or chewable
A doctor first suggested calcium to 57% of respondents
We asked everyone who first suggested calcium supplements to them. The answer sets where the habit begins.
Who First Suggested Calcium Supplements to You?
Single choice, % of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| My doctor | 57% |
| Family or friends | 14% |
| A pharmacist | 13% |
| Something I saw online or on TV | 8% |
| I picked them myself | 8% |
01. The doctor lead over family or friends is 43 points. Doctor and family or friends together account for 71% of first suggestions.
02. Among those who took calcium in the last 3 months, 59.3% name their doctor. Among those who last took it 3 to 12 months ago the figure is 55.6%, on a small base the report marks as indicative.
03. The report could not rank the unaided reasons for taking calcium, and it could not split first suggestion by age band.
59% took calcium in the last 3 months, and 36% have lapsed
We asked when each person last took a calcium supplement.
When Did You Last Take a Calcium Supplement?
Single choice, % of respondents. Base: 100. A further 5.0% slice is unlabelled in the report.
View the data behind this chart
| Answer | Share |
|---|---|
| In the last 3 months | 59% |
| 3 to 12 months ago | 36% |
Respondent Age Profile
% of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| 18-24 | 8% |
| 24-35 | 22% |
| 35-45 | 28% |
| 45-55 | 26% |
| 56-90 | 16% |
01. Current takers lead lapsed takers by 23 points. Roughly one in three has stopped within the past year.
02. The sample leans towards midlife adults: 54% are aged 35 to 55. By city it splits Delhi 30%, Bangalore 26%, Mumbai 25% and Jaipur 19%, and by gender 59% male and 41% female.
03. The report could not cross-tabulate takers by age, gender, city or who the supplement is for, so a lead segment cannot yet be chosen.
Tablets are known to 62%, liquids to only 35%
We asked which calcium formats people have heard of.
Awareness of Each Calcium Supplement Format
% of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| Tablets | 62% |
| Capsules | 58% |
| Gummies | 51% |
| Chewables | 49% |
| Powders | 46% |
| Liquids | 35% |
01. Tablets and capsules lead awareness, and the report did not test the gap between them. Gummies (51%) and chewables (49%) are known to about half.
02. Past-year use by format was not usable. The report's own format funnel showed 0% use at the final step, and it flags that result as unreliable. Awareness alone does not show which format has white space.
Price (81%) and doctor advice (80%) top eight closely bunched drivers
We asked which drivers matter most when choosing a calcium supplement. The chart shows the share naming each driver in their top two.
Purchase Drivers Named in the Top Two
Multiple answers allowed, % of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| Price | 81% |
| Doctor's recommendation | 80% |
| Format (tablet, gummy, powder and so on) | 76% |
| Consistency (works the same every time) | 75% |
| Pack size | 75% |
| Ingredient transparency | 73% |
| Taste | 68% |
| Packaging | 63% |
01. The spread from first to last is only 18 points, so most buyers weigh several things at once. The survey did not produce the MaxDiff scores that would rank the eight drivers.
02. Price is named by a similar share of women (82.9%) and men (79.7%), though the report marks this as an indicative, small-base read.
Online (68%) and pharmacy (67%) are level, and 77% use two or more channels
We asked where people buy, or would buy, calcium supplements. They could pick every channel that applies.
Where Do You Buy, or Would You Buy, Calcium Supplements?
Multiple answers allowed, % of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| Online apps and sites (1mg, Healthkart, Amazon) | 68% |
| Pharmacy or chemist | 67% |
| Doctor's clinic | 53% |
| Supermarket or hypermarket | 44% |
| Brand's own website | 40% |
| Kirana or general store | 29% |
Number of Purchase Channels Named
% of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| Two or more channels | 77% |
| Exactly one channel | 23% |
01. Online and pharmacy are one point apart, and no test found a difference. The doctor's clinic follows at 53%.
02. Among the 30 respondents in Delhi, 80% name online and 50% name a supermarket. That base is small and the report calls it indicative. Other cities were not shown.
03. Monthly spend in rupees was not in the data, so price tiers cannot be set from this study.
77% would try a gummy or chewable, but 55% worry about side effects
We asked whether people would try a different form, like a gummy or chewable, instead of their usual brand, and what puts them off taking calcium.
Would You Try a Different Form Instead of Your Usual Brand?
Single choice, % of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| Definitely would try | 34% |
| Probably would try | 43% |
| Might or might not | 18% |
| Probably would not | 3% |
| Definitely would not | 2% |
What Would Put You Off Taking Calcium?
Multiple answers allowed, % of respondents. Base: 100
View the data behind this chart
| Answer | Share |
|---|---|
| Side effects | 55% |
| Forgetting to take it | 55% |
| Cost | 54% |
| Taste | 50% |
| Hard to swallow | 47% |
| Nothing puts me off | 4% |
01. Only 5% would probably or definitely not try a new form. 77% would probably or definitely try one.
02. Barriers are widespread. Side effects and forgetting tie at 55%, with a gap of 0 points, and only 4% say nothing puts them off. 98% of men and 93% of women name at least one barrier, though the women figure is indicative.
03. The report could not break trial intent or barriers down by age band or by format.
What we would recommend
Practical priorities drawn from this study for further validation.
Anchor messaging on doctor advice.
57.0% name a doctor as the first suggester, 43 points ahead of family or friends, and 80.0% put doctor's recommendation in their top two purchase drivers.
Sell through online and pharmacy together.
The two are level at 68.0% and 67.0%, and 77.0% of respondents name two or more channels. A single-channel launch would miss most buyers.
Test a gummy or chewable.
77.0% would probably or definitely try a different form. Awareness of gummies (51.0%) and chewables (49.0%) is lower than tablets (62.0%), so education may be needed.
Plan for forgetting and side-effect worries.
Each puts off 55.0% of respondents, and cost 54.0%. With 36.0% having lapsed in the past year, retention deserves as much attention as acquisition.
Run a larger, ranked study before fixing pack claims.
Price (81.0%) and doctor advice (80.0%) are almost level, brand and format use could not be read, and the base is 100. A MaxDiff test on a bigger sample would settle the lead driver.